TestCloud
Prep • Practice • Perform
Log In

Oxford Launches First Human Trials for Nipah Virus Vaccine.

Science & Technology | Dated: 15 Jan 2026

The University of Oxford has launched the first-in-human clinical trials for a vaccine against the deadly Nipah virus. The vaccine, ChAdOx1 NipahB, uses the same viral vector technology as the Oxford-AstraZeneca COVID-19 vaccine. The trial aims to assess the safety and immunogenicity of the vaccine.

🎯 Key Highlights:

  • Nipah virus is a zoonotic virus with a high fatality rate (40-75%).
  • It is transmitted from fruit bats to humans and animals.
  • Currently, there are no approved vaccines or treatments for Nipah virus infection.

💡 Other Important Facts:

  • Vaccine Trial: ChAdOx1 NipahB.
  • Developer: Oxford University.
  • Target: Nipah Virus.

📚 Test Your Knowledge:

Which university has launched the first human trials for a vaccine against the Nipah virus?

Correct Answer: University of Oxford

🚀 Quick Recap:

About Nipah Virus

  • Host – Fruit Bats
  • First Outbreak – Malaysia (1998)